These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3091903)

  • 1. Potential role of carnitine in patients with renal insufficiency.
    Wanner C; Hörl WH
    Klin Wochenschr; 1986 Jul; 64(13):579-86. PubMed ID: 3091903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis.
    Wanner C; Förstner-Wanner S; Schaeffer G; Schollmeyer P; Hörl WH
    Am J Nephrol; 1986; 6(3):206-11. PubMed ID: 3740128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure.
    Moorthy AV; Rosenblum M; Rajaram R; Shug AL
    Am J Nephrol; 1983; 3(4):205-8. PubMed ID: 6614070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of kidney transplantation on carnitine metabolism.
    Kohse KP; Dech E; Rössle C; Franz HE; Fürst P
    Clin Nephrol; 1988 Apr; 29(4):199-205. PubMed ID: 3284670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.
    Marín VB; Azocar M; Molina M; Guerrero JL; Ratner R; Cano F
    Adv Perit Dial; 2006; 22():130-5. PubMed ID: 16983956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of hemodialysis on carnitine levels in children with chronic renal failure.
    Mir S; Kantar M; Yalaz M; Keskinoglu A; Coker I; Huseyinov A
    Pediatr Int; 2002 Feb; 44(1):70-3. PubMed ID: 11982875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease.
    Evans AM; Faull RJ; Nation RL; Prasad S; Elias T; Reuter SE; Fornasini G
    Kidney Int; 2004 Oct; 66(4):1527-34. PubMed ID: 15458447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA metabolism in uremic patients: accumulation of modified ribonucleosides in uremic serum. Technical note.
    Niwa T; Takeda N; Yoshizumi H
    Kidney Int; 1998 Jun; 53(6):1801-6. PubMed ID: 9607216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma and Lp(a)-associated PAF-acetylhydrolase activity in uremic patients undergoing different dialysis procedures.
    Milionis HJ; Elisaf MS; Karabina SA; Bairaktari E; Tselepis AD; Siamopoulos KC
    Kidney Int; 1999 Dec; 56(6):2276-85. PubMed ID: 10594806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
    Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatic decrease of carnitine esters after interruption of exogenous carnitine supply in hemodialysis patients.
    Bene J; Csiky B; Wittmann I; Sulyok E; Melegh B
    Ren Fail; 2012; 34(5):555-8. PubMed ID: 22417076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hemodialysis session on the dynamics of carnitine ester profile changes in L-carnitine pretreated end-stage renal disease patients.
    Csiky B; Bene J; Wittmann I; Sulyok E; Melegh B
    Int Urol Nephrol; 2013 Jun; 45(3):847-55. PubMed ID: 22684763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid-lowering effect of carnitine in chronically uremic patients treated with maintenance hemodialysis.
    Guarnieri GF; Ranieri F; Toigo G; Vasile A; Ciman M; Rizzoli V; Moracchiello M; Campanacci L
    Am J Clin Nutr; 1980 Jul; 33(7):1489-92. PubMed ID: 7395772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of different carnitine levels for improving the prognosis of patients undergoing hemodialysis.
    Zhang YM; Zhuo L; Hu J; Cui G; Zhang L; Zhang XL; Li WG
    Ren Fail; 2016 Nov; 38(10):1654-1658. PubMed ID: 27758157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine deficiency induced during hemodialysis and hyperlipidemia: effect of replacement therapy.
    Bertoli M; Battistella PA; Vergani L; Naso A; Gasparotto ML; Romagnoli GF; Angelini C
    Am J Clin Nutr; 1981 Aug; 34(8):1496-500. PubMed ID: 7270472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perturbation of serum carnitine levels in human adults by chronic renal disease and dialysis therapy.
    Bartel LL; Hussey JL; Shrago E
    Am J Clin Nutr; 1981 Jul; 34(7):1314-20. PubMed ID: 7258121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.